To explore whether thalamic implantation in stereoEEG should be considered standard clinical practice or restricted to IRB-approved research, emphasizing the implications for patient care.
Key Findings:
Proponents argue thalamic SEEG is safe and beneficial for patient outcomes, emphasizing its clinical applications.
Opponents cite lack of evidence from randomized controlled trials to support thalamic recordings, stressing the need for rigorous testing.
Variability in expertise and protocols across institutions complicates the interpretation of thalamic SEEG results, potentially affecting patient safety.
Interpretation:
The debate centers on balancing patient safety, ethical considerations regarding risk, and the need for robust evidence to support clinical practices.
Limitations:
Current evidence is primarily based on expert opinion and retrospective studies, lacking randomized controlled trials, which may introduce bias.
Variability in clinical practices and patient selection may affect the outcomes of thalamic SEEG.
Conclusion:
The discussion highlights the complexity of integrating thalamic SEEG into standard practice without sufficient evidence, urging centers to make informed decisions while considering the ethical implications and potential patient outcomes.
Guidance addresses office readiness, recommended equipment and medications, and team communication processes for infrequent but high-acuity emergencies.
